Natural Compound Obakulactone Shows Promise in Rheumatoid Arthritis Treatment
Researchers have identified a natural compound, obakulactone (OL), derived from Phellodendri cortex, that may offer a new treatment pathway for rheumatoid arthritis. The study, published in Engineering, found that OL targets fatty acid metabolism, promoting the breakdown of acyl coenzyme A thioesterase 1 (ACOT1) and restoring balance in unsaturated fatty acids linked to inflammation. In experimental models, OL reduced joint swelling and improved tissue structure in rats with induced rheumatoid arthritis. The compound also shifted immune cell types and decreased inflammatory markers, suggesting a potential alternative to traditional immune-suppressing treatments.